IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $659.41 million. The enterprise value is $609.13 million.
| Market Cap | 659.41M |
| Enterprise Value | 609.13M |
Important Dates
The last earnings date was Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | May 20, 2025 |
Share Statistics
IRMD has 12.72 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 36.75% |
| Owned by Institutions (%) | 48.51% |
| Float | 7.13M |
Valuation Ratios
The trailing PE ratio is 33.46 and the forward PE ratio is 31.05.
| PE Ratio | 33.46 |
| Forward PE | 31.05 |
| PS Ratio | 8.75 |
| Forward PS | 8.14 |
| PB Ratio | 7.32 |
| P/TBV Ratio | 7.60 |
| P/FCF Ratio | 45.16 |
| P/OCF Ratio | 25.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.99, with an EV/FCF ratio of 41.72.
| EV / Earnings | 30.79 |
| EV / Sales | 8.11 |
| EV / EBITDA | 25.99 |
| EV / EBIT | 26.90 |
| EV / FCF | 41.72 |
Financial Position
The company has a current ratio of 8.87, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.87 |
| Quick Ratio | 7.44 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.81% and return on invested capital (ROIC) is 16.83%.
| Return on Equity (ROE) | 23.81% |
| Return on Assets (ROA) | 14.92% |
| Return on Invested Capital (ROIC) | 16.83% |
| Return on Capital Employed (ROCE) | 24.29% |
| Revenue Per Employee | $469,716 |
| Profits Per Employee | $123,656 |
| Employee Count | 160 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.49 |
Taxes
In the past 12 months, IRMD has paid $5.19 million in taxes.
| Income Tax | 5.19M |
| Effective Tax Rate | 20.79% |
Stock Price Statistics
The stock price has increased by +20.71% in the last 52 weeks. The beta is 0.92, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +20.71% |
| 50-Day Moving Average | 52.27 |
| 200-Day Moving Average | 52.13 |
| Relative Strength Index (RSI) | 47.81 |
| Average Volume (20 Days) | 34,359 |
Short Selling Information
The latest short interest is 198,373, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 198,373 |
| Short Previous Month | 206,808 |
| Short % of Shares Out | 1.56% |
| Short % of Float | 2.78% |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, IRMD had revenue of $75.15 million and earned $19.78 million in profits. Earnings per share was $1.55.
| Revenue | 75.15M |
| Gross Profit | 57.80M |
| Operating Income | 22.65M |
| Pretax Income | 23.60M |
| Net Income | 19.78M |
| EBITDA | 23.43M |
| EBIT | 22.65M |
| Earnings Per Share (EPS) | $1.55 |
Balance Sheet
The company has $50.33 million in cash and $59,221 in debt, giving a net cash position of $50.27 million or $3.95 per share.
| Cash & Cash Equivalents | 50.33M |
| Total Debt | 59,221 |
| Net Cash | 50.27M |
| Net Cash Per Share | $3.95 |
| Equity (Book Value) | 90.05M |
| Book Value Per Share | 7.08 |
| Working Capital | 66.66M |
Cash Flow
In the last 12 months, operating cash flow was $26.03 million and capital expenditures -$11.43 million, giving a free cash flow of $14.60 million.
| Operating Cash Flow | 26.03M |
| Capital Expenditures | -11.43M |
| Free Cash Flow | 14.60M |
| FCF Per Share | $1.15 |
Margins
Gross margin is 76.91%, with operating and profit margins of 30.13% and 26.33%.
| Gross Margin | 76.91% |
| Operating Margin | 30.13% |
| Pretax Margin | 33.23% |
| Profit Margin | 26.33% |
| EBITDA Margin | 31.18% |
| EBIT Margin | 30.13% |
| FCF Margin | 19.43% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 1.30%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 1.30% |
| Dividend Growth (YoY) | -17.95% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 43.88% |
| Buyback Yield | -0.50% |
| Shareholder Yield | 0.79% |
| Earnings Yield | 3.00% |
| FCF Yield | 2.21% |
Analyst Forecast
The average price target for IRMD is $72.00, which is 37.38% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.00 |
| Price Target Difference | 37.38% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 35.18 and a Piotroski F-Score of 5.
| Altman Z-Score | 35.18 |
| Piotroski F-Score | 5 |